Table 1 Clinico-pathological characteristics in 261 patients of lung adenocarcinomas
From: Heterogeneous components of lung adenocarcinomas confer distinct EGFR mutation and PD-L1 expression
| N | % | |
|---|---|---|
| Gender | ||
| Male | 131 | 50.2 |
| Female | 130 | 49.8 |
| Histological types (predominant components) | ||
| Acinar | 90 | 34.5 |
| Lepidic | 14 | 5.4 |
| Micropapillary | 22 | 8.4 |
| Mucinous | 10 | 3.8 |
| Papillary | 66 | 25.3 |
| Solid | 59 | 22.6 |
| ALK fusion gene | ||
| Positive | 17 | 6.5 |
| Negative | 244 | 93.5 |
| EGFR Status | ||
| Mutated | 154 | 59 |
| Wild-typed | 107 | 41 |
| Clinical Stage | ||
| IA | 69 | 26.4 |
| IB | 27 | 10.3 |
| IIA | 7 | 2.7 |
| IIB | 14 | 5.4 |
| IIIA | 79 | 30.3 |
| IIIB+IV | 65 | 24.9 |